Grail (GRAL) | Stock Overview & Key Data

What is GRAL's 52-week high and low?

In the last 52 weeks, Grail reached a high of $63.99 (on February 18, 2025) and a low of $12.33 (on October 7, 2024).

What is the market cap and P/E ratio for GRAL?

Curious about Grail's size and valuation? Its market capitalization stands at 1.51B. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.70, and the forward P/E (looking ahead) is -3.39.

Does GRAL pay dividends? If so, what's the yield?

As for dividends, Grail isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Grail's main competitors or similar companies to consider before investing?

When looking at Grail, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Thermo Fisher TMO	152.45B	Healthcare	Diagnostics & Research	-20.51%	-22.46%
Danaher DHR	140.51B	Healthcare	Diagnostics & Research	-15.07%	-13.10%
Twist Bioscience TWST	2.15B	Healthcare	Diagnostics & Research	-21.25%	-9.70%
Opko Health OPK	1.01B	Healthcare	Diagnostics & Research	7.94%	-51.60%
Neogen NEOG	1.04B	Healthcare	Diagnostics & Research	-65.00%	-77.21%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Grail Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Grail's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -62.22%, the Debt to Equity ratio from the most recent quarter is 2.67, and its Gross Profit Margin stands at -62.60%.

What is the recent revenue and earnings growth for GRAL?

Looking at Grail's growth, its revenue over the trailing twelve months (TTM) was $131M. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.10%, and quarterly earnings saw a YoY growth of 19.15%.

How much of GRAL stock is held by insiders and institutions?

Wondering who owns Grail stock? Company insiders (like executives and directors) hold about 14.18% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 66.35%.

For more common questions about our data, please visit our About Data page.